6:49 PM
 | 
Feb 28, 2013
 |  BC Extra  |  Financial News

Kala raises $11.5 million in series A

Kala Pharmaceuticals Inc. (Waltham, Mass.) raised $11.5 million in a series A led by new investor Crown Venture Fund. Existing investors Lux...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >